1-8 of 8
Brian C Cooley, PhD
Close
Sort by
Journal Articles

Platelet CD36 Promotes ERK5 and Caspase-Dependent Procoagulant Phosphatidylserine Externalization and In Vivo Fibrin Formation in Dyslipidemia

Moua Yang, PhD, Andaleb Kholmukhamedov, MD, Marie L Schulte, PhD, Brian C Cooley, PhD, Na'il O Scoggins, Jeremy P. Wood, PhD, Scott J Cameron, MDPhD, Craig Morrell, DVM, PhD, Shawn M. Jobe, MD PhD, Roy L. Silverstein, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 867.
https://doi.org/10.1182/blood-2018-99-111204
Published: 2018
Journal Articles

CD36 Promotes Platelet Phosphatidylserine Exposure through MAP Kinase ERK5

Moua Yang, Andaleb Kholmukhamedov, MD, Na'il O Scoggins, Brian C Cooley, PhD, Craig Morrell, DVM, PhD, Shawn M. Jobe, MD PhD, Roy L. Silverstein, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2303.
https://doi.org/10.1182/blood.V130.Suppl_1.2303.2303
Published: 2017
Journal Articles

Platelet CD36 Potentiates Thrombus Formation in Hyperlipidemic Conditions By Activating Redox Sensitive MAP Kinase ERK5

Moua Yang, BS, Brian C. Cooley, PhD, Yiliang Chen, PhD, Jeannette M. Vasquez-Vivar, PhD, Na'il O. Scoggins, Scott J. Cameron, PhD MD, Craig N. Morrell, DVM, PhD, Roy L. Silverstein, MD
Journal: Blood
Blood (2016) 128 (22): 710.
https://doi.org/10.1182/blood.V128.22.710.710
Published: 2016
Journal Articles

Bleeding in Factor XI Deficient Mice

Cihan Ay, MD, Yohei Hisada, PhD, Brian C. Cooley, PhD, Nigel Mackman, PhD
Journal: Blood
Blood (2016) 128 (22): 3766.
https://doi.org/10.1182/blood.V128.22.3766.3766
Published: 2016
Journal Articles

Alteration of the Structure and Dynamics of Venous Clot Formation in Human and Murine Sickle Cell Disease

Camille Faes, PhD, Anton Ilich, MD, Erica M Sparkenbaugh, PhD, Alisa S. Wolberg, PhD, Brian C. Cooley, PhD, Kenneth I. Ataga, MD, Nigel S. Key, MB, ChB, FRCP,, Rafal Pawlinski, PhD
Journal: Blood
Blood (2016) 128 (22): 2478.
https://doi.org/10.1182/blood.V128.22.2478.2478
Published: 2016
Journal Articles

PAR-4 Deficiency Rescues The Embryonic Lethal Phenotype Of TFPI Null Mice

Paul E. R. Ellery, PhD, Susan A. Maroney, DVM, PhD, Brian C. Cooley, PhD, Mark Zogg, BS, Hartmut Weiler, PhD, Alan E. Mast, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 199.
https://doi.org/10.1182/blood.V122.21.199.199
Published: 2013
Journal Articles

Combined Tissue Factor Pathway Inhibitor (TFPI) and Thrombomodulin (TM) Deficiency Produces an Augmented Hypercoagulable State with Tissue Specific Fibrin Deposition.

Susan A. Maroney, DVM, PhD, Brian C. Cooley, PhD, Rashmi Sood, PhD, Hartmut Weiler, PhD, Alan E. Mast, MD PhD
Journal: Blood
Blood (2007) 110 (11): 265.
https://doi.org/10.1182/blood.V110.11.265.265
Published: 2007
Journal Articles

Mechanisms for Mortality Reduction by Activated Protein C in Severe Sepsis.

Edward J. Kerschen, PhD, Brian C. Cooley, PhD, Francis J. Castellino, PhD, Shaun R. Coughlin, MD, PhD, Jose A. Fernandez, MD, PhD, John H. Griffin, PhD, Hartmut Weiler, PhD
Journal: Blood
Blood (2006) 108 (11): 1.
https://doi.org/10.1182/blood.V108.11.1.1
Published: 2006